Alicia C. Marin
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Evaluating the Immunological Impact of Hepatitis B Vaccination in Patients with Inflammatory Bowel Disease.
Journal: International journal of molecular sciences
Published: December 12, 2025
Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases.
Journal: International journal of molecular sciences
Published: December 02, 2024
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Journal: International journal of molecular sciences
Published: February 24, 2021
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
Journal: The American journal of gastroenterology
Published: November 06, 2020
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract.
Journal: Molecular nutrition & food research
Published: October 29, 2020
Serum adipokines as non-invasive biomarkers in Crohn's disease.
Journal: Scientific reports
Published: July 01, 2020
A quick flow cytometry protocol to assess Helicobacter pylori viability.
Journal: Journal of microbiological methods
Published: April 21, 2020
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease.
Journal: European journal of gastroenterology & hepatology
Published: April 07, 2020
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: February 05, 2020
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease.
Journal: Nutrients
Published: September 20, 2019
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.
Journal: Therapeutic advances in gastroenterology
Published: April 10, 2019
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease.
Journal: Mucosal immunology
Published: December 14, 2017
Last Updated: 09/26/2026